Skip to Main Content

Author Details

Kevin A Nguyen
Veterans Affairs Palo Alto Healthcare System, Stanford University School of Medicine
2017
52
13
PMIDPaper TitleJournal TitlePublished Year
36302223Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020.Oncologist2023
35843481Yield of sentinel lymph node biopsy in sebaceous carcinoma and predictors of advanced disease: A retrospective analysis of the National Cancer Database.J Am Acad Dermatol2023
37439382Patterns and determinants of pediatric dermatologic care in the United States: An evaluation of the National Ambulatory Medical Care Survey from 2009 to 2015.Pediatr Dermatol2023
34143433Response to "Mohs surgery for early-stage Merkel cell carcinoma (MCC) achieves local control better than wide local excision +/- radiation therapy with no increase in MCC-specific death".Int J Dermatol2022
35486675Decreased risk of rheumatic skin diseases in HIV/AIDS inpatients.Clin Exp Dermatol2022
33722548Psoriasis in liver disease: Associations beyond nonalcoholic fatty liver disease.J Am Acad Dermatol2022
34499993Synergistic effect of lymphovascular invasion and nodal involvement on prognosis in Merkel cell carcinoma: A retrospective analysis in the National Cancer Database.J Am Acad Dermatol2022
34537251Risk factors for and prognostic impact of positive surgical margins after excision of Merkel cell carcinoma.J Am Acad Dermatol2022
34293387Prognostic value of lymphovascular invasion in early-stage Merkel cell carcinoma: A retrospective analysis in the National Cancer Database.J Am Acad Dermatol2022
33934332Competing risk analysis of cutaneous angiosarcoma: implications for surveillance.Int J Dermatol2022
31103604Association Between Twitter Reception at a National Urology Conference and Future Publication Status.Eur Urol Focus2021
33887064The burden of immune-mediated skin disease in inpatients with HIV/AIDS.Br J Dermatol2021
34550749Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.JCO Oncol Pract2021
33112465Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: A review.Dermatol Ther2021
33471163Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries.World J Urol2021
32972793Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.Eur Urol2021
32781190Sites of distant metastasis in Merkel cell carcinoma differ by primary tumor site and are of prognostic significance: A population-based study in the Surveillance, Epidemiology, and End Results database from 2010 to 2016.J Am Acad Dermatol2021
33010311Autoimmune skin diseases associated with inpatient primary biliary cholangitis.J Am Acad Dermatol2021
32562045National trends in the management of patients with positive surgical margins at radical prostatectomy.World J Urol2021
31147263Outcomes of Serial Multiparametric Magnetic Resonance Imaging and Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed with Active Surveillance.Eur Urol Focus2021
31483493Cutaneous spindle cell sarcoma: a population-based study in the surveillance, epidemiology, and end results database from 1975 to 2016.Int J Dermatol2020
34017908The Association Between the Affordable Care Act and Insurance Status, Stage and Treatment in Patients with Testicular Cancer.Urol Pract2020
31829435Primary mucoepidermoid carcinoma of the skin: a retrospective investigation in the Surveillance, Epidemiology, and End Results Database from 1975 to 2016.Int J Dermatol2020
32555206Specificity of end resection pathways for double-strand break regions containing ribonucleotides and base lesions.Nat Commun2020
30561791Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.Cancer2019
30059717Determinants of Active Surveillance in Patients With Small Renal Masses.Urology2019
31519468Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study.Clin Genitourin Cancer2019
31397958Patient experiences with biologics and apremilast in pityriasis rubra pilaris: A patient survey.Dermatol Ther2019
31012833Outcomes of upper tract urothelial cancer managed non-surgically.Can J Urol2019
30829780Comparison of Mohs Surgery and Surgical Excision in the Treatment of Localized Sebaceous Carcinoma.Dermatol Surg2019
31047733Role of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy.Eur Urol2019
30587401National trends and economic impact of surgical treatment for benign kidney tumors.Urol Oncol2019
28972702Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.BJU Int2018
30224356A DNA nick at Ku-blocked double-strand break ends serves as an entry site for exonuclease 1 (Exo1) or Sgs1-Dna2 in long-range DNA end resection.J Biol Chem2018
29676444Ethnic disparity in primary cutaneous CD30<sup>+</sup> T-cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer Database.Br J Haematol2018
29669169Genetic testing for hereditary prostate cancer: Current status and limitations.Cancer2018
29602182Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal involvement: an analysis of 1306 cases from the US National Cancer Database.Br J Haematol2018
29760223Genomic Heterogeneity and the Small Renal Mass.Clin Cancer Res2018
28980517Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients.Leuk Lymphoma2018
29214867Disease site as a determinant of survival outcome in patients with primary cutaneous peripheral T-cell lymphoma, unspecified: an analysis of 4057 cases from the US National Cancer Database.Leuk Lymphoma2018
27805307Distinguishing pediatric and adolescent renal cell carcinoma from other renal malignancies.Pediatr Blood Cancer2017
28787086Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.Cancer2017
28645647Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database.J Am Acad Dermatol2017
29020620Enhancement of BLM-DNA2-Mediated Long-Range DNA End Resection by CtIP.Cell Rep2017
28967967Optimizing waiting duration for renal transplants in the setting of renal malignancy: is 2â¿¿years too long to wait?Nephrol Dial Transplant2017
28322902Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy.Urology2017
28501565Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion-targeted biopsy in patients with a solitary PI-RADS v2-scored lesion.Urol Oncol2017
28449978Author Reply.Urology2017
28220449Current Management Strategy for Active Surveillance in Prostate Cancer.Curr Oncol Rep2017
28436365Adverse pathologic characteristics in the small renal mass: implications for active surveillance.Can J Urol2017
  • 1 - 50 of 52

Recommended Authors

institute of urology
Career Start Year 2016
Number of shared co-authors 3
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 2
Loyola University, Illinois Edward Hines Veteran Affairs Hospital
Career Start Year 2011
Number of shared co-authors 0
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 4
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 5
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Sandra and Edward Meyer Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
University of Florida
Career Start Year 2005
Number of shared co-authors 1
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 0
University of Virginia
Career Start Year 2002
Number of shared co-authors 0
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 5
The Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 2
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 2
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 1996
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 0
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 3
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 2

Collaborators

Yale School of Medicine
Co-authored papers 21
University of California los angeles
Co-authored papers 16
Yale University School of Medicine
Co-authored papers 5
Yale School of Medicine
Co-authored papers 3
Yale University
Co-authored papers 3
Institute of Urologic Oncology, University of California Los Angeles
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 1
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Cedars Sinai Medical Center
Co-authored papers 1
University of California los angeles
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Co-authored papers 1